Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year.

Slides:

Advertisements

Similar presentations

Literature Search Strategy Used for the MEDLINE Database Gami AS, et al. J Am Coll Cardiol 2007;49:

Advertisements

Nonsense Mutations in PCSK9 and Cardiovascular Risk Factors among 3363 Black Participants in the Study Jonathan C.Cohen, et al, N Engl J Med 2006;354:

HYPERLIPIDAEMIA. 4S 4444 patients –Hx angina or MI –Cholesterol Simvastatin 20mg (10-40) vs. placebo FU 5 years  total cholesterol 25%;  LDL.

Characteristics of 3921 Men Seen by a Primary Care Provider Steven A. Grover, et al, Arch Intern Med. 2005;166:

Quartiles of complete blood count components Jeffrey L. Anderson, et al. Am J Cardiol 2007;99:

Baseline Characteristics of Individuals From the General Population by Quartiles of Triglyceride Levels a Børge G. Nordestgaard, et al. JAMA 2007;298:

WOSCOPS: West Of Scotland Coronary Prevention Study Purpose To determine whether pravastatin reduces combined incidence of nonfatal MI and death due to.

Slide Source: Lipids Online Slide Library LDL Cholesterol, mg/dL Years of Follow-up Ridker PM et al. N Engl J Med 2002;347:1557–1565.

Patient disposition Dichtl W, et al. Am J Cardiol. 2008;102:743-8 AVR = aortic valve replacement; MDCT = multidetector computed tomographic.

Ridker PM, et al. Lancet 2009;373: Baseline clinical characteristics of the study population in the placebo and rosuvastatin groups according.

Baseline characteristics of participants presenting with or without peripheral artery disease (PAD) Heart Protection Study Group J Vasc Surg 2007;45:

Trial profile The FIELD study investigators, Lancet Published online November 14, 2005.

Baseline characteristics and eligibility criteria of participating trials Cholesterol Treatment Trialists’ (CTT) Collaborators Lancet 2005;366:

Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.

Date of download: 6/29/2016 Copyright © The American College of Cardiology. All rights reserved. From: A Test in Context: High-Sensitivity C-Reactive Protein.

Date of download: 7/8/2016 Copyright © The American College of Cardiology. All rights reserved. From: 10-Year Coronary Heart Disease Risk Prediction Using.

Multivariate associations* between selected covariates and statin use Jawahar L. Mehta, et al. Am J Cardiol 2006;98:923–928.

Date of download: 9/18/2016 Copyright © The American College of Cardiology. All rights reserved. From: Implications of Coronary Artery Calcium Testing.

Baseline Characteristics of the Patients Part I

Baseline Characteristics of Women and Men in Whom Coronary Heart Disease Developed during Follow-up and Matched Controls - A Jennifer K. Pai et al. N.

Clinical Characteristics

HDL cholesterol and cardiovascular risk Epidemiological evidence

HDL cholesterol and cardiovascular risk

TNT: Baseline and final LDL cholesterol levels

by John T. Wilkins, Hongyan Ning, Neil J. Stone, Michael H

Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment:

Figure 7 Mendelian randomization of overlapping exposures

Sunjoo Boo, RN, PhD, Erika Sivarajan Froelicher, RN, PhD, FAAN

Nat. Rev. Cardiol. doi: /nrcardio

Effect of evolocumab on lipoprotein particles

Jun M, et al. Lancet 2010 Epub May 10

Selmer R, et al. Br J Clin Pharmacol 2009;67:355-62

OR (95% CI) for CHD associated with inflammatory markers before and after adjustment for established risk factors. OR (95% CI) for CHD associated with.

Primary and Secondary Prevention of Cardiovascular Disease

Description of studies for pooled analyses

Fung TT, et al. Circulation 2009;119:

Nat. Rev. Cardiol. doi: /nrcardio

Figure 3 Mendelian randomization (MR) using a genetic

Receiver operating curves (ROC) of the Framingham and QRISK2 risk factor models for predicting 10-year risk of cardiovascular disease with and without.

Khurram Nasir et al. JACC 2015;66:

Baseline Characteristics

Ratio of relative risks of heart disease and stroke associated with higher blood pressure, smoking, type I and II diabetes, and higher cholesterol in women.

Baseline Characteristics of Cardiovascular Risk Factors and Selected Dietary Variables in a Cohort of 22,881 Men and 35,091 Women to Quintile of Fish Intakes.

Baseline Characteristics by Baseline N-BNP Level

Baseline Characteristics by Tertiles of Homocysteine

Distribution of Cardiovascular Risk Factors by Baseline CRP Concentration M. Cushman et al. Circulation. 2005;112:25-31.

Heart Protection Study Collaborative Group Lancet 2011;377:469-76

Baseline Patients with coronary artery disease (CAD) and high (n=98) versus normal (n=1512) high-density lipoprotein (HDL) levels Doreen DeFaria Yeh, et.

Baseline Characteristics of the Study Participants

Cause of death Treatment-arm events, % (n=45 054)

Baseline Clinical Characteristics

Baseline Characteristics of Study Subjects

Baseline Characteristics of the Subjects*

Baseline characteristics for patients with diabetes in ASCOT-LLA Part I P.S. SEVER et al Diabetes Care 2005; 28: 1151–1157.

Baseline Characteristics

Age-specific mortality rates from CHD and stroke in women and men in 2010 in selected countries. Age-specific mortality rates from CHD and stroke in women.

The accuracy of the Framingham risk-score in different socioeconomic groups: a prospective study by Peter M Brindle, Alex McConnachie, Mark N Upton, Carole.

Characteristics of included studies

Baseline plasma levels of cathepsin D (A), cathepsin L (B) and cystatin B (C) are increased in individuals who developed coronary events (CEs) during follow-up.

PROSPER: trial design

Flow chart of search strategy

Comparison of Baseline Characteristics by Primary End Point

Adjusted relative risk Adjusted odds ratio

Occupational Life Expectancy in England & Wales,

Flow of study participants

Risk for cardiovascular disease and all-cause death according to RHR: (A) as categorical variable (HR≥75 bpm vs HR

Risk ratio (RR) and number needed to treat (NNT) are time-dependent measures. a) When an intervention is associated with constant relative risk reduction.

Kaplan-Meier survival (renal event-free) curves during follow-up by tertiles of plasma copeptin. Kaplan-Meier survival (renal event-free) curves during.

Changes of major clinical and biochemical characteristics at baseline and during follow-up in different groups. Changes of major clinical and biochemical.

The cumulative incidence curve demonstrated that patients with a sub-optimal LDL-C response to statin therapy were associated with a higher risk of CVD.

Presentation transcript:

Baseline characteristics of the 1,842 men without coronary heart disease and the 230 men with a first coronary heart disease event during the 13-year follow-up Annie C. St-Pierre, et al. Am J Cardiol 2006;97:997-1001

The relative risks (RR) of CHD in each tertile of plasma apo-B and LDL cholesterol (LDL-C) levels were computed by using men in the first tertile as a reference group (RR 1.0) Annie C. St-Pierre, et al. Am J Cardiol 2006;97:997-1001

Synergistic effect of LDL cholesterol (LDL-C) levels and apo-B concentrations on the 13-year relative risk of CHD Annie C. St-Pierre, et al. Am J Cardiol 2006;97:997-1001

Synergistic effect of the risk associated with the Framingham risk score and apo-B concentrations on the 13-year relative risk of CHD Annie C. St-Pierre, et al. Am J Cardiol 2006;97:997-1001

Area under the receiver-operating characteristics curves Annie C. St-Pierre, et al. Am J Cardiol 2006;97:997-1001